Townsquare Capital LLC Axogen, Inc. Transaction History

Townsquare Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Nov 13, 2023	SELL	$8.5 - $10.38 $37,612 - $45,931	-4,425 Reduced 13.93%	27,337 $249,000
Q1 2023 May 11, 2023	SELL	$7.53 - $10.95 $13,953 - $20,290	-1,853 Reduced 5.51%	31,762 $300,000
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $21,693 - $30,080	2,298 Added 7.34%	33,615 $335,000
Q3 2022 Nov 10, 2022	BUY	$8.14 - $12.25 $1,693 - $2,548	208 Added 0.67%	31,317 $374,000
Q2 2022 Aug 08, 2022	BUY	$6.99 - $10.0 $8,765 - $12,540	1,254 Added 4.2%	31,109 $255,000
Q1 2022 Apr 28, 2022	BUY	$7.26 - $10.7 $137,155 - $202,144	18,892 Added 172.33%	29,855 $237,000
Q4 2021 Feb 11, 2022	SELL	$8.8 - $16.0 $43,384 - $78,880	-4,930 Reduced 31.02%	10,963 $103,000
Q3 2021 Nov 15, 2021	BUY	$15.23 - $21.72 $78,602 - $112,096	5,161 Added 48.09%	15,893 $251,000
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $191,029 - $252,202	10,732 New	10,732 $232,000

178

36.5M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $745M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.